Literature DB >> 11487735

The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose.

S G Hasselbalch1, S Holm, H S Pedersen, C Svarer, G M Knudsen, P L Madsen, O B Paulson.   

Abstract

Quantification of regional cerebral glucose metabolism (CMRglc) using positron emission tomography and 18F-fluorodeoxyglucose (PET-FDG) requires knowledge of the correction factor between FDG and glucose net clearance, the FDG lumped constant (LC). Because diverging values for LC have been obtained, the authors reevaluated LC by measuring the ratio of the cerebral net extraction fractions of FDG (E*) and glucose (E) from arteriovenous cerebral measurements. Thirty subjects were studied (mean age = 25 +/- 4 years): 12 during a programed infusion of FDG and 18 after a bolus injection of FDG. In the infusion study, LC was calculated as the ratio E*/E. In the bolus study, E* was calculated from the slope of a Patlak-Gjedde plot. Lumped constant was significantly smaller in the infusion study as compared with the bolus study (0.48 +/- 0.16 vs. 0.81 +/- 0.27, P < 0.001). In 4 subjects studied during continuous FDG infusion for 2.5 hours, LC decreased to 0.36 +/- 0.11. These results suggest that the "steady-state" method underestimates LC because E* continues to decline because of significant labeled product. Further, the authors provide evidence for resetting of LC toward a greater value. The subsequent resetting of CMRglc provides a physiologically more meaningful estimate and allows for comparison of CMRglc values between different methodologies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487735     DOI: 10.1097/00004647-200108000-00012

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

1.  Simplified [18F]FDG image-derived input function using the left ventricle, liver, and one venous blood sample.

Authors:  Mohammed Noor Tantawy; Todd E Peterson
Journal:  Mol Imaging       Date:  2010-04       Impact factor: 4.488

2.  Dynamic functional imaging of brain glucose utilization using fPET-FDG.

Authors:  Marjorie Villien; Hsiao-Ying Wey; Joseph B Mandeville; Ciprian Catana; Jonathan R Polimeni; Christin Y Sander; Nicole R Zürcher; Daniel B Chonde; Joanna S Fowler; Bruce R Rosen; Jacob M Hooker
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

3.  Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Authors:  Nicolas A Karakatsanis; Yun Zhou; Martin A Lodge; Michael E Casey; Richard L Wahl; Habib Zaidi; Arman Rahmim
Journal:  Phys Med Biol       Date:  2015-10-28       Impact factor: 3.609

Review 4.  Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

5.  Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery.

Authors:  Jaakko Mäkinen; Jarna C Hannukainen; Anna Karmi; Heidi M Immonen; Minna Soinio; Lassi Nelimarkka; Nina Savisto; Mika Helmiö; Jari Ovaska; Paulina Salminen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetologia       Date:  2015-01-29       Impact factor: 10.122

Review 6.  FDG-PET imaging in mild traumatic brain injury: a critical review.

Authors:  Kimberly R Byrnes; Colin M Wilson; Fiona Brabazon; Ramona von Leden; Jennifer S Jurgens; Terrence R Oakes; Reed G Selwyn
Journal:  Front Neuroenergetics       Date:  2014-01-09

7.  The Effects of Capillary Transit Time Heterogeneity (CTH) on the Cerebral Uptake of Glucose and Glucose Analogs: Application to FDG and Comparison to Oxygen Uptake.

Authors:  Hugo Angleys; Sune N Jespersen; Leif Østergaard
Journal:  Front Comput Neurosci       Date:  2016-10-13       Impact factor: 2.380

8.  Four decades of mapping and quantifying neuroreceptors at work in vivo by positron emission tomography.

Authors:  Albert Gjedde; Dean F Wong
Journal:  Front Neurosci       Date:  2022-09-08       Impact factor: 5.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.